Advertisement
Case highlights the nuance of managing kidney disease in patients undergoing chemotherapy
Clinical implications for key updates published in the KDIGO 2021 Clinical Practice Guideline
Early experiences and outcomes on the brink of 200 cases
New findings could shape the treatment paradigm for a select group of bladder cancer patients
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
First in-human-trial for diagnostic bladder disorder device
Infectious disease and kidney transplant specialists share key insights
Demographic and social factors found to influence preemptive listing
Decision-making models improve Black patients' understanding of screening protocols
Large validation study corroborates previous findings, sets the stage for clinical use
Study is the first double-blinded randomized controlled trial to evaluate a non-opiate analgesic regimen after ureteroscopy (URS)
Advertisement
Advertisement